GNL Gut and Liver
  1. Eun Ju Cho. Predicting Risk in Primary Biliary Cholangitis. Gut and Liver 2023;17:491
    https://doi.org/10.5009/gnl230239
  2. Sylvia Drazilova, Tomas Koky, Marian Macej, Martin Janicko, Dagmar Simkova, Peter Jarcuska. The treatment of primary biliary cholangitis: from shadow to light. Therap Adv Gastroenterol 2024;17
    https://doi.org/10.1177/17562848241265782
  3. Guilherme Grossi Lopes Cançado, Nathalia Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, Debora Raquel Benedita Terrabuio, Cristiane Alves Villela-Nogueira, Michelle Harriz Braga, Mateus Jorge Nardelli, Luciana Costa Faria, Elze Maria Gomes Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone Muniz Carvalho Fernandes da Cunha, Daniel Ferraz de Campos Mazo, Liliana Sampaio Costa Mendes, Claudia Alexandra Pontes Ivantes, Liana Codes, Valéria Ferreira de Almeida e Borges, Fabio Heleno de Lima Pace, Mário Guimarães Pessôa, Izabelle Venturini Signorelli, Gabriela Perdomo Coral, Paulo Lisboa Bittencourt, Patrícia Fucuta, Roberto José de Carvalho Filho, Maria Lucia Gomes Ferraz. A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score. 2024;36:628
    https://doi.org/10.1097/MEG.0000000000002744
  4. Juan Feng, Jia-Min Xu, Hai-Yan Fu, Nan Xie, Wei-Min Bao, Ying-Mei Tang. Prognostic scores in primary biliary cholangitis patients with advanced disease. World J Gastrointest Surg 2023;15:1774
    https://doi.org/10.4240/wjgs.v15.i8.1774
  5. Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek. Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver disease: a nationwide case-control study in South Korea. Virol J 2024;21
    https://doi.org/10.1186/s12985-024-02464-1
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd